Pfizer Inc. (NYSE: PFE) stock closed at 38.97 per share at the end of the most recent trading day (a -0.31% change compared to the prior day closing price) with a volume of 19.69M shares and market capitalization of 220.00B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 78500 people. Pfizer Inc. CEO is Albert Bourla.

The one-year performance of Pfizer Inc. stock is -24.51%, while year-to-date (YTD) performance is -23.95%. PFE stock has a five-year performance of 6.27%. Its 52-week range is between 36.17 and 54.93, which gives PFE stock a 52-week price range ratio of 14.93%

Pfizer Inc. currently has a PE ratio of 9.80, a price-to-book (PB) ratio of 3.09, a price-to-sale (PS) ratio of 3.57, a price to cashflow ratio of 11.00, a PEG ratio of 2.32, a ROA of 17.15%, a ROC of 25.39% and a ROE of 37.98%. The company’s profit margin is 34.72%, its EBITDA margin is 39.50%, and its revenue ttm is $76.04 Billion , which makes it $13.55 revenue per share.

Of the last four earnings reports from Pfizer Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.63 for the next earnings report. Pfizer Inc.’s next earnings report date is 27th Jul 2023.

The consensus rating of Wall Street analysts for Pfizer Inc. is Moderate Buy (2.2), with a target price of $57.4, which is +47.29% compared to the current price. The earnings rating for Pfizer Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Pfizer Inc. has a dividend yield of 3.39% with a dividend per share of $1.64 and a payout ratio of 92.00%.

Pfizer Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 6.45, ATR14 : 0.81, CCI20 : 108.02, Chaikin Money Flow : 0.03, MACD : 0.00, Money Flow Index : 71.16, ROC : -1.69, RSI : 54.49, STOCH (14,3) : 65.49, STOCH RSI : 0.86, UO : 50.07, Williams %R : -34.51), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Pfizer Inc. in the last 12-months were: Albert Bourla (Option Excercise at a value of $6 058 579), Angela Hwang (Option Excercise at a value of $464 049), Douglas M. Lankler (Option Excercise at a value of $2 672 547), Hwang Angela (Option Excercise at a value of $1 720 655), Jennifer B. Damico (Option Excercise at a value of $570 681), Jennifer B. Damico (Sold 9 912 shares of value $396 678 ), Johnson Rady (Option Excercise at a value of $1 722 445), Michael McDermott (Option Excercise at a value of $324 534), Mikael Dolsten (Option Excercise at a value of $2 627 259), Payal Sahni (Option Excercise at a value of $204 202), Rady A. Johnson (Option Excercise at a value of $770 340), Sahni Payal (Option Excercise at a value of $663 057), Sally Susman (Option Excercise at a value of $1 670 603), Susman Sally (Option Excercise at a value of $3 964 820)